Search Results 1851-1860 of 7455 for fsa eligible items on amazon

  1. Clinical Impact of Cardiac Photon Counting CT

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  2. CY 6031 Study Will Evaluate The Effects Of Treatment With Aficamten (CK-3773274) Over A 24-week Period On Cardiopulmonary Exercise Capacity And Health Status In Patients With Symptomatic OHCM - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  3. Andrew J. Fagan, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

  4. A Study Of Ripretinib Vs Sunitinib In Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. High-dose Hydroxocobalamin (Vitamin B12a) for Vasopressor Refractory Hypotension Following Cardiopulmonary Bypass - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  6. Evaluation Of C-Scan Capsule In Identifying Subjects With Elevated Risk Of Colon Polyps - Mayo Clinic

    Standard colonoscopy procedure will be performed within 60 days following the C-Scan Cap swallowing. Participation eligibility. Participant eligibility includes ...

  7. Study To Evaluate The Safety, Tolerability And Efficacy Of CT1812 In Subjects With Mild To Moderate Dementia With Lewy Bodies - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. Open-Label Study Of The CDK4/6 Inhibitor SPH4336 In Subjects With Locally Advanced Or Metastatic Liposarcomas - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. R-3750 In Patients With Mild To Moderate Ulcerative Colitis - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  10. SX-682 Treatment In Subjects With Myelodysplastic Syndrome Who Had Disease Progression Or Are Intolerant To Prior Therapy - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...